Recent studies indicate that chronic inflammation is convincingly linked to higher risks of psychiatric disorders, prompting a reevaluation of mental health mechanisms beyond neurotransmitter imbalances.
Chronic low-level inflammation disrupts neurotransmitter function, the HPA axis, and neuroplasticity, which are critical for mental health, potentially leading to an increase in various psychiatric disorders.
The '6S' framework for managing inflammation, focusing on factors like sugar intake and sleep quality, could effectively reduce risks associated with mental health issues.
Emerging treatments, including anti-inflammatory drugs and GLP-1 medications, offer promise for addressing mental health challenges by targeting inflammatory pathways traditionally overlooked in psychiatric care.
Collection
[
|
...
]